Drug Supply Chain Transparency

Regulation

fda.gov·July 18, 2026

FDA Proposes Rule to Modernize Drug Manufacturing Registration

The FDA’s proposed rule would create a single registration pathway for distributed manufacturing networks and clarify registration duties for certain foreign drug manufacturers.